Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för John N Nunnelly. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att John N Nunnelly har rapporterat innehav eller affärer i följande företag:
| Värdepapper | Titel | Senaste rapporterade innehav |
|---|---|---|
| US:NRC / NRC Health | Director | 32 666 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av John N Nunnelly. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderköp NRC / NRC Health - Analys av kortsiktig vinst
I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i NRC / NRC Health. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.
| Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till max |
Pris vid max |
Max vinst ($) |
Maximal avkastning (%) |
|---|---|---|---|---|---|---|---|
| Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderförsäljning - Analys av kortsiktig förlust
I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i NRC / NRC Health. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av John N Nunnelly som avslöjats för Securities Exchange Commission (SEC).
| Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-29 |
|
4 | NRC |
NATIONAL RESEARCH CORP
Common Stock |
F - Taxes | −3 487 | 32 666 | −9,65 | 39,70 | −138 434 | 1 296 840 | |
| 2024-03-29 |
|
4 | NRC |
NATIONAL RESEARCH CORP
Common Stock |
M - Exercise | 9 259 | 36 153 | 34,43 | 14,95 | 138 422 | 540 487 | |
| 2022-05-20 |
|
4 | NRC |
NATIONAL RESEARCH CORP
Director Stock Option (Right to Buy) |
A - Award | 12 078 | 12 078 | |||||
| 2021-07-01 |
|
4 | NRC |
NATIONAL RESEARCH CORP
Director Stock Option (Right to Buy) |
A - Award | 7 289 | 7 289 | |||||
| 2020-07-27 |
|
4 | NRC |
NATIONAL RESEARCH CORP
Director Stock Option (Right to Buy) |
M - Exercise | −40 | 10 400 | −0,38 | ||||
| 2020-07-27 |
|
4 | NRC |
NATIONAL RESEARCH CORP
Director Stock Option (Right to Buy) |
M - Exercise | −6 821 | 0 | −100,00 | ||||
| 2020-07-27 |
|
4 | NRC |
NATIONAL RESEARCH CORP
Director Stock Option (Right to Buy) |
M - Exercise | −5 926 | 22 837 | −20,60 | ||||
| 2020-07-27 |
|
4 | NRC |
NATIONAL RESEARCH CORP
Common Stock |
S - Sale | X | −5 926 | 26 894 | −18,06 | 60,10 | −356 164 | 1 616 380 |
| 2020-07-27 |
|
4 | NRC |
NATIONAL RESEARCH CORP
Common Stock |
F - Taxes | −6 861 | 32 820 | −17,29 | 58,94 | −404 387 | 1 934 411 | |
| 2020-07-27 |
|
4 | NRC |
NATIONAL RESEARCH CORP
Common Stock |
M - Exercise | 40 | 39 681 | 0,10 | 34,90 | 1 396 | 1 384 867 | |
| 2020-07-27 |
|
4 | NRC |
NATIONAL RESEARCH CORP
Common Stock |
M - Exercise | 6 821 | 39 641 | 20,78 | 50,62 | 345 279 | 2 006 627 | |
| 2020-07-27 |
|
4 | NRC |
NATIONAL RESEARCH CORP
Common Stock |
M - Exercise | 5 926 | 32 820 | 22,03 | 9,74 | 57 719 | 319 667 | |
| 2020-05-20 |
|
4 | NRC |
NATIONAL RESEARCH CORP
Director Stock Option (Right to Buy) |
A - Award | 7 179 | 7 179 | |||||
| 2019-06-05 |
|
4 | NRC |
NATIONAL RESEARCH CORP
Director Stock Option (Right to Buy) |
A - Award | 6 821 | 6 821 | |||||
| 2019-01-22 |
|
4 | NRC |
NATIONAL RESEARCH CORP
Director Stock Option (Right to Buy) |
A - Award | 10 440 | 10 440 | |||||
| 2018-05-25 |
|
4 | NRCI |
NATIONAL RESEARCH CORP
Director Stock Option (Right to Buy) |
M - Exercise | −116 | 9 259 | −1,24 | ||||
| 2018-05-25 |
|
4 | NRCI |
NATIONAL RESEARCH CORP
Common Stock |
S - Sale | X | −2 153 | 26 894 | −7,41 | 34,37 | −74 003 | 924 401 |
| 2018-05-25 |
|
4 | NRCI |
NATIONAL RESEARCH CORP
Common Stock |
S - Sale | X | −2 913 | 29 047 | −9,11 | 33,51 | −97 615 | 973 365 |
| 2018-05-25 |
|
4 | NRCI |
NATIONAL RESEARCH CORP
Common Stock |
F - Taxes | −50 | 31 960 | −0,16 | 34,55 | −1 728 | 1 104 218 | |
| 2018-05-25 |
|
4 | NRCI |
NATIONAL RESEARCH CORP
Common Stock |
M - Exercise | 116 | 32 010 | 0,36 | 14,95 | 1 734 | 478 550 | |
| 2018-05-23 |
|
4 | NRCI |
NATIONAL RESEARCH CORP
Director Stock Option (Right to Buy) |
M - Exercise | −10 881 | 9 375 | −53,72 | ||||
| 2018-05-23 |
|
4 | NRCI |
NATIONAL RESEARCH CORP
Common Stock |
S - Sale | X | −6 111 | 31 894 | −16,08 | 34,30 | −209 604 | 1 093 948 |
| 2018-05-23 |
|
4 | NRCI |
NATIONAL RESEARCH CORP
Common Stock |
F - Taxes | −4 770 | 38 005 | −11,15 | 34,10 | −162 657 | 1 295 970 | |
| 2018-05-23 |
|
4 | NRCI |
NATIONAL RESEARCH CORP
Common Stock |
M - Exercise | 10 881 | 42 775 | 34,12 | 14,95 | 162 671 | 639 486 | |
| 2018-05-23 |
|
4 | NRCI |
NATIONAL RESEARCH CORP
Director Stock Option (Right to Buy) |
M - Exercise | −12 794 | 20 256 | −38,71 | ||||
| 2018-05-23 |
|
4 | NRCI |
NATIONAL RESEARCH CORP
Common Stock |
S - Sale | X | −7 290 | 31 894 | −18,60 | 34,66 | −252 691 | 1 105 532 |
| 2018-05-23 |
|
4 | NRCI |
NATIONAL RESEARCH CORP
Common Stock |
F - Taxes | −5 504 | 39 184 | −12,32 | 34,75 | −191 264 | 1 361 644 | |
| 2018-05-23 |
|
4 | NRCI |
NATIONAL RESEARCH CORP
Common Stock |
M - Exercise | 12 794 | 44 688 | 40,11 | 14,95 | 191 270 | 668 086 | |
| 2018-05-21 |
|
4 | NRCI |
NATIONAL RESEARCH CORP
Director Stock Option (Right to Buy) |
M - Exercise | −2 950 | 33 050 | −8,19 | ||||
| 2018-05-21 |
|
4 | NRCI |
NATIONAL RESEARCH CORP
Director Stock Option (Right to Buy) |
M - Exercise | −10 043 | 0 | −100,00 | ||||
| 2018-05-21 |
|
4 | NRCI |
NATIONAL RESEARCH CORP
Common Stock |
S - Sale | X | −899 | 31 894 | −2,74 | 34,88 | −31 359 | 1 112 530 |
| 2018-05-21 |
|
4 | NRCI |
NATIONAL RESEARCH CORP
Common Stock |
S - Sale | X | −5 900 | 32 793 | −15,25 | 34,44 | −203 217 | 1 129 509 |
| 2018-05-21 |
|
4 | NRCI |
NATIONAL RESEARCH CORP
Common Stock |
F - Taxes | −1 278 | 38 693 | −3,20 | 34,50 | −44 091 | 1 334 908 | |
| 2018-05-21 |
|
4 | NRCI |
NATIONAL RESEARCH CORP
Common Stock |
M - Exercise | 2 950 | 39 971 | 7,97 | 14,95 | 44 102 | 597 566 | |
| 2018-05-21 |
|
4 | NRCI |
NATIONAL RESEARCH CORP
Common Stock |
F - Taxes | −4 916 | 37 021 | −11,72 | 34,50 | −169 602 | 1 277 224 | |
| 2018-05-21 |
|
4 | NRCI |
NATIONAL RESEARCH CORP
Common Stock |
M - Exercise | 10 043 | 41 937 | 31,49 | 16,89 | 169 626 | 708 316 | |
| 2018-05-21 |
|
4 | NRCI |
NATIONAL RESEARCH CORP
Director Stock Option (Right to Buy) |
M - Exercise | −25 957 | 10 043 | −72,10 | ||||
| 2018-05-21 |
|
4 | NRCI |
NATIONAL RESEARCH CORP
Director Stock Option (Right to Buy) |
M - Exercise | −7 821 | 0 | −100,00 | ||||
| 2018-05-21 |
|
4 | NRCI |
NATIONAL RESEARCH CORP
Common Stock |
S - Sale | X | −24 979 | 31 894 | −43,92 | 34,71 | −866 911 | 1 106 900 |
| 2018-05-21 |
|
4 | NRCI |
NATIONAL RESEARCH CORP
Common Stock |
F - Taxes | −12 580 | 56 873 | −18,11 | 34,85 | −438 413 | 1 982 024 | |
| 2018-05-21 |
|
4 | NRCI |
NATIONAL RESEARCH CORP
Common Stock |
M - Exercise | 25 957 | 69 453 | 59,68 | 16,89 | 438 414 | 1 173 061 | |
| 2018-05-21 |
|
4 | NRCI |
NATIONAL RESEARCH CORP
Common Stock |
F - Taxes | −5 464 | 43 496 | −11,16 | 34,85 | −190 420 | 1 515 836 | |
| 2018-05-21 |
|
4 | NRCI |
NATIONAL RESEARCH CORP
Common Stock |
M - Exercise | 7 821 | 48 960 | 19,01 | 24,35 | 190 441 | 1 192 176 | |
| 2018-05-17 |
|
4 | NRCI |
NATIONAL RESEARCH CORP
Director Stock Option (Right to Buy) |
M - Exercise | −17 483 | 7 821 | −69,09 | ||||
| 2018-05-17 |
|
4 | NRCI |
NATIONAL RESEARCH CORP
Common Stock |
S - Sale | X | −5 952 | 41 139 | −12,64 | 34,67 | −206 384 | 1 426 487 |
| 2018-05-17 |
|
4 | NRCI |
NATIONAL RESEARCH CORP
Common Stock |
F - Taxes | −12 286 | 47 091 | −20,69 | 34,65 | −425 710 | 1 631 703 | |
| 2018-05-17 |
|
4 | NRCI |
NATIONAL RESEARCH CORP
Common Stock |
M - Exercise | 17 483 | 59 377 | 41,73 | 24,35 | 425 711 | 1 445 830 | |
| 2018-05-16 |
|
4 | NRCI |
NATIONAL RESEARCH CORP
Director Stock Option (Right to Buy) |
M - Exercise | −10 696 | 25 304 | −29,71 | ||||
| 2018-05-16 |
|
4 | NRCI |
NATIONAL RESEARCH CORP
Director Stock Option (Right to Buy) |
M - Exercise | −5 874 | 0 | −100,00 | ||||
| 2018-05-16 |
|
4 | NRCI |
NATIONAL RESEARCH CORP
Common Stock |
S - Sale | X | −6 602 | 41 894 | −13,61 | 34,51 | −227 827 | 1 445 712 |
| 2018-05-16 |
|
4 | NRCI |
NATIONAL RESEARCH CORP
Common Stock |
F - Taxes | −7 549 | 48 496 | −13,47 | 34,50 | −260 440 | 1 673 112 | |
| 2018-05-16 |
|
4 | NRCI |
NATIONAL RESEARCH CORP
Common Stock |
M - Exercise | 10 696 | 56 045 | 23,59 | 24,35 | 260 448 | 1 364 696 | |
| 2018-05-16 |
|
4 | NRCI |
NATIONAL RESEARCH CORP
Common Stock |
F - Taxes | −2 419 | 45 349 | −5,06 | 34,50 | −83 456 | 1 564 540 | |
| 2018-05-16 |
|
4 | NRCI |
NATIONAL RESEARCH CORP
Common Stock |
M - Exercise | 5 874 | 47 768 | 14,02 | 14,21 | 83 470 | 678 783 | |
| 2018-05-16 |
|
4 | NRCI |
NATIONAL RESEARCH CORP
Director Stock Option (Right to Buy) |
M - Exercise | −27 885 | 5 874 | −82,60 | ||||
| 2018-05-16 |
|
4 | NRCI |
NATIONAL RESEARCH CORP
Common Stock |
S - Sale | X | −16 383 | 41 894 | −28,11 | 34,46 | −564 537 | 1 443 613 |
| 2018-05-16 |
|
4 | NRCI |
NATIONAL RESEARCH CORP
Common Stock |
F - Taxes | −11 502 | 58 277 | −16,48 | 34,45 | −396 244 | 2 007 643 | |
| 2018-05-16 |
|
4 | NRCI |
NATIONAL RESEARCH CORP
Common Stock |
M - Exercise | 27 885 | 69 779 | 66,56 | 14,21 | 396 246 | 991 560 | |
| 2018-05-14 |
|
4 | NRCI |
NATIONAL RESEARCH CORP
Director Stock Option (Right to Buy) |
M - Exercise | −2 241 | 33 759 | −6,22 | ||||
| 2018-05-14 |
|
4 | NRCI |
NATIONAL RESEARCH CORP
Director Stock Option (Right to Buy) |
M - Exercise | −1 703 | 0 | −100,00 | ||||
| 2018-05-14 |
|
4 | NRCI |
NATIONAL RESEARCH CORP
Common Stock |
S - Sale | X | −2 314 | 41 894 | −5,23 | 34,13 | −78 980 | 1 429 892 |
| 2018-05-14 |
|
4 | NRCI |
NATIONAL RESEARCH CORP
Common Stock |
F - Taxes | −927 | 44 208 | −2,05 | 34,35 | −31 842 | 1 518 545 | |
| 2018-05-14 |
|
4 | NRCI |
NATIONAL RESEARCH CORP
Common Stock |
M - Exercise | 2 241 | 45 135 | 5,22 | 14,21 | 31 845 | 641 368 | |
| 2018-05-14 |
|
4 | NRCI |
NATIONAL RESEARCH CORP
Common Stock |
F - Taxes | −703 | 42 894 | −1,61 | 34,35 | −24 148 | 1 473 409 | |
| 2018-05-14 |
|
4 | NRCI |
NATIONAL RESEARCH CORP
Common Stock |
M - Exercise | 1 703 | 43 597 | 4,07 | 14,19 | 24 166 | 618 641 | |
| 2018-05-14 |
|
4 | NRCI |
NATIONAL RESEARCH CORP
Director Stock Option (Right to Buy) |
M - Exercise | −10 607 | 1 703 | −86,17 | ||||
| 2018-05-14 |
|
4 | NRCI |
NATIONAL RESEARCH CORP
Common Stock |
S - Sale | X | −16 200 | 41 894 | −27,89 | 33,86 | −548 558 | 1 418 598 |
| 2018-05-14 |
|
4 | NRCI |
NATIONAL RESEARCH CORP
Common Stock |
F - Taxes | −4 407 | 58 094 | −7,05 | 34,15 | −150 499 | 1 983 910 | |
| 2018-05-14 |
|
4 | NRCI |
NATIONAL RESEARCH CORP
Common Stock |
M - Exercise | 10 607 | 62 501 | 20,44 | 14,19 | 150 513 | 886 889 | |
| 2018-05-10 |
|
4 | NRCI |
NATIONAL RESEARCH CORP
Director Stock Option (Right to Buy) |
M - Exercise | −15 029 | 12 310 | −54,97 | ||||
| 2018-05-10 |
|
4 | NRCI |
NATIONAL RESEARCH CORP
Common Stock |
S - Sale | X | −8 654 | 51 894 | −14,29 | 33,31 | −288 239 | 1 728 433 |
| 2018-05-10 |
|
4 | NRCI |
NATIONAL RESEARCH CORP
Common Stock |
F - Taxes | −6 375 | 60 548 | −9,53 | 33,45 | −213 244 | 2 025 331 | |
| 2018-05-10 |
|
4 | NRCI |
NATIONAL RESEARCH CORP
Common Stock |
M - Exercise | 15 029 | 66 923 | 28,96 | 14,19 | 213 262 | 949 637 | |
| 2018-05-09 |
|
4 | NRCI |
NATIONAL RESEARCH CORP
Director Stock Option (Right to Buy) |
M - Exercise | −3 797 | 27 339 | −12,19 | ||||
| 2018-05-09 |
|
4 | NRCI |
NATIONAL RESEARCH CORP
Common Stock |
S - Sale | X | −2 194 | 51 894 | −4,06 | 33,47 | −73 443 | 1 737 131 |
| 2018-05-09 |
|
4 | NRCI |
NATIONAL RESEARCH CORP
Common Stock |
F - Taxes | −1 603 | 54 088 | −2,88 | 33,60 | −53 861 | 1 817 357 | |
| 2018-05-09 |
|
4 | NRCI |
NATIONAL RESEARCH CORP
Common Stock |
M - Exercise | 3 797 | 55 691 | 7,32 | 14,19 | 53 879 | 790 255 | |
| 2018-05-09 |
|
4 | NRCI |
NATIONAL RESEARCH CORP
Director Stock Option (Right to Buy) |
M - Exercise | −4 864 | 31 136 | −13,51 | ||||
| 2018-05-09 |
|
4 | NRCI |
NATIONAL RESEARCH CORP
Director Stock Option (Right to Buy) |
M - Exercise | −5 938 | 0 | −100,00 | ||||
| 2018-05-09 |
|
4 | NRCI |
NATIONAL RESEARCH CORP
Common Stock |
S - Sale | X | −4 100 | 51 894 | −7,32 | 34,60 | −141 843 | 1 795 314 |
| 2018-05-09 |
|
4 | NRCI |
NATIONAL RESEARCH CORP
Common Stock |
S - Sale | X | −2 300 | 55 994 | −3,95 | 33,92 | −78 013 | 1 899 255 |
| 2018-05-09 |
|
4 | NRCI |
NATIONAL RESEARCH CORP
Common Stock |
F - Taxes | −4 402 | 58 294 | −7,02 | 34,30 | −150 989 | 1 999 484 | |
| 2018-05-09 |
|
4 | NRCI |
NATIONAL RESEARCH CORP
Common Stock |
M - Exercise | 4 864 | 62 696 | 8,41 | 14,19 | 69 020 | 889 656 | |
| 2018-05-09 |
|
4 | NRCI |
NATIONAL RESEARCH CORP
Common Stock |
M - Exercise | 5 938 | 57 832 | 11,44 | 13,81 | 82 004 | 798 660 | |
| 2018-05-07 |
|
4 | NRCI |
NATIONAL RESEARCH CORP
Common Stock |
F - Taxes | −2 751 | 56 017 | −4,68 | 34,50 | −94 910 | 1 932 586 | |
| 2018-05-07 |
|
4 | NRCI |
NATIONAL RESEARCH CORP
Common Stock |
M - Exercise | 6 874 | 58 768 | 13,25 | 13,81 | 94 930 | 811 586 | |
| 2018-05-07 |
|
4 | NRCI |
NATIONAL RESEARCH CORP
Director Stock Option (Right to Buy) |
M - Exercise | −6 874 | 5 938 | −53,65 | ||||
| 2018-05-07 |
|
4 | NRCI |
NATIONAL RESEARCH CORP
Director Stock Option (Right to Buy) |
M - Exercise | −23 188 | 12 812 | −64,41 | ||||
| 2018-05-07 |
|
4 | NRCI |
NATIONAL RESEARCH CORP
Common Stock |
S - Sale | X | −4 123 | 51 894 | −7,36 | 34,69 | −143 018 | 1 800 089 |
| 2018-05-07 |
|
4 | NRCI |
NATIONAL RESEARCH CORP
Common Stock |
S - Sale | X | −11 433 | 51 894 | −18,05 | 34,53 | −394 773 | 1 791 863 |
| 2018-05-07 |
|
4 | NRCI |
NATIONAL RESEARCH CORP
Common Stock |
S - Sale | X | −2 500 | 63 327 | −3,80 | 34,02 | −85 042 | 2 154 182 |
| 2018-05-07 |
|
4 | NRCI |
NATIONAL RESEARCH CORP
Common Stock |
F - Taxes | −9 255 | 65 827 | −12,33 | 34,60 | −320 223 | 2 277 614 | |
| 2018-05-07 |
|
4 | NRCI |
NATIONAL RESEARCH CORP
Common Stock |
M - Exercise | 23 188 | 75 082 | 44,68 | 13,81 | 320 226 | 1 036 882 | |
| 2018-04-18 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Director Stock Option (Right to Buy) |
D - Sale to Issuer | −6 000 | 0 | −100,00 | ||||
| 2018-04-18 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Director Stock Option (Right to Buy) |
D - Sale to Issuer | −6 000 | 0 | −100,00 | ||||
| 2018-04-18 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Director Stock Option (Right to Buy) |
D - Sale to Issuer | −6 000 | 0 | −100,00 | ||||
| 2018-04-18 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Director Stock Option (Right to Buy) |
D - Sale to Issuer | −6 000 | 0 | −100,00 | ||||
| 2018-04-18 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Director Stock Option (Right to Buy) |
D - Sale to Issuer | −6 000 | 0 | −100,00 | ||||
| 2018-04-18 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Director Stock Option (Right to Buy) |
D - Sale to Issuer | −6 000 | 0 | −100,00 | ||||
| 2018-04-18 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Director Stock Option (Right to Buy) |
D - Sale to Issuer | −6 000 | 0 | −100,00 | ||||
| 2018-04-18 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Director Stock Option (Right to Buy) |
D - Sale to Issuer | −6 000 | 0 | −100,00 | ||||
| 2018-04-18 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Common Stock |
A - Award | 19 294 | 51 894 | 59,18 | ||||
| 2018-04-18 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Common Stock |
A - Award | 3 900 | 32 600 | 13,59 | ||||
| 2018-04-18 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class B Common Stock |
D - Sale to Issuer | −3 900 | 0 | −100,00 | ||||
| 2018-04-04 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Director Stock Option (Right to Buy) |
M - Exercise | −4 561 | 28 763 | −13,69 | ||||
| 2018-04-04 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class A Common Stock |
S - Sale | −3 000 | 28 700 | −9,46 | 28,75 | −86 250 | 825 125 | |
| 2018-04-04 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class A Common Stock |
F - Taxes | −1 561 | 31 700 | −4,69 | 28,45 | −44 410 | 901 865 | |
| 2018-04-04 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class A Common Stock |
M - Exercise | 4 561 | 33 261 | 15,89 | 9,74 | 44 424 | 323 962 | |
| 2018-04-02 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Director Stock Option (Right to Buy) |
M - Exercise | −149 | 33 324 | −0,45 | ||||
| 2018-04-02 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class A Common Stock |
S - Sale | −100 | 28 700 | −0,35 | 29,50 | −2 950 | 846 650 | |
| 2018-04-02 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class A Common Stock |
F - Taxes | −49 | 28 800 | −0,17 | 29,25 | −1 433 | 842 400 | |
| 2018-04-02 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class A Common Stock |
M - Exercise | 149 | 28 849 | 0,52 | 9,74 | 1 451 | 280 989 | |
| 2018-03-29 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Director Stock Option (Right to Buy) |
M - Exercise | −2 527 | 33 473 | −7,02 | ||||
| 2018-03-29 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Director Stock Option (Right to Buy) |
M - Exercise | −3 235 | 0 | −100,00 | ||||
| 2018-03-29 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class A Common Stock |
S - Sale | −4 068 | 28 700 | −12,41 | 28,87 | −117 441 | 828 552 | |
| 2018-03-29 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class A Common Stock |
F - Taxes | −847 | 32 768 | −2,52 | 29,05 | −24 605 | 951 910 | |
| 2018-03-29 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class A Common Stock |
F - Taxes | −847 | 32 768 | −2,52 | 29,05 | −24 605 | 951 910 | |
| 2018-03-29 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class A Common Stock |
M - Exercise | 2 527 | 33 615 | 8,13 | 9,74 | 24 613 | 327 410 | |
| 2018-03-29 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class A Common Stock |
M - Exercise | 3 235 | 31 935 | 11,27 | 7,61 | 24 618 | 243 025 | |
| 2018-03-28 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Director Stock Option (Right to Buy) |
M - Exercise | −135 | 3 235 | −4,01 | ||||
| 2018-03-28 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class A Common Stock |
S - Sale | −100 | 28 700 | −0,35 | 29,15 | −2 915 | 836 605 | |
| 2018-03-28 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class A Common Stock |
F - Taxes | −35 | 28 800 | −0,12 | 28,95 | −1 013 | 833 760 | |
| 2018-03-28 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class A Common Stock |
M - Exercise | 135 | 28 835 | 0,47 | 7,61 | 1 027 | 219 434 | |
| 2018-03-28 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Director Stock Option (Right to Buy) |
M - Exercise | −6 660 | 3 370 | −66,40 | ||||
| 2018-03-28 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class A Common Stock |
S - Sale | −8 | 28 700 | −0,03 | 28,70 | −230 | 823 690 | |
| 2018-03-28 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class A Common Stock |
S - Sale | −4 883 | 28 708 | −14,54 | 28,65 | −139 898 | 822 484 | |
| 2018-03-28 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class A Common Stock |
F - Taxes | −1 769 | 33 591 | −5,00 | 28,65 | −50 682 | 962 382 | |
| 2018-03-28 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class A Common Stock |
M - Exercise | 6 660 | 35 360 | 23,21 | 7,61 | 50 683 | 269 090 | |
| 2018-03-26 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Director Stock Option (Right to Buy) |
M - Exercise | −347 | 10 030 | −3,34 | ||||
| 2018-03-26 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class A Common Stock |
S - Sale | −216 | 28 700 | −0,75 | 29,50 | −6 372 | 846 650 | |
| 2018-03-26 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class A Common Stock |
S - Sale | −40 | 28 916 | −0,14 | 31,00 | −1 240 | 896 396 | |
| 2018-03-26 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class A Common Stock |
F - Taxes | −91 | 28 956 | −0,31 | 28,95 | −2 634 | 838 276 | |
| 2018-03-26 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class A Common Stock |
M - Exercise | 347 | 29 047 | 1,21 | 7,61 | 2 641 | 221 048 | |
| 2018-03-26 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Director Stock Option (Right to Buy) |
M - Exercise | −132 | 10 377 | −1,26 | ||||
| 2018-03-26 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class A Common Stock |
S - Sale | −100 | 28 700 | −0,35 | 31,20 | −3 120 | 895 440 | |
| 2018-03-26 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class A Common Stock |
F - Taxes | −32 | 28 800 | −0,11 | 30,80 | −986 | 887 040 | |
| 2018-03-26 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class A Common Stock |
M - Exercise | 132 | 28 832 | 0,46 | 7,61 | 1 005 | 219 412 | |
| 2018-03-22 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class A Common Stock |
S - Sale | −5 000 | 28 700 | −14,84 | 31,10 | −155 500 | 892 570 | |
| 2018-03-22 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Director Stock Option (Right to Buy) |
M - Exercise | −7 433 | 10 509 | −41,43 | ||||
| 2018-03-22 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class A Common Stock |
S - Sale | −612 | 33 700 | −1,78 | 31,40 | −19 217 | 1 058 180 | |
| 2018-03-22 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class A Common Stock |
F - Taxes | −1 821 | 34 312 | −5,04 | 31,05 | −56 542 | 1 065 388 | |
| 2018-03-22 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class A Common Stock |
M - Exercise | 7 433 | 36 133 | 25,90 | 7,61 | 56 565 | 274 972 | |
| 2018-03-20 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Director Stock Option (Right to Buy) |
M - Exercise | −3 142 | 17 942 | −14,90 | ||||
| 2018-03-20 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class A Common Stock |
S - Sale | −2 383 | 28 700 | −7,67 | 31,74 | −75 642 | 911 007 | |
| 2018-03-20 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class A Common Stock |
F - Taxes | −759 | 31 083 | −2,38 | 31,50 | −23 908 | 979 114 | |
| 2018-03-20 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class A Common Stock |
M - Exercise | 3 142 | 31 842 | 10,95 | 7,61 | 23 911 | 242 318 | |
| 2017-07-05 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Director Stock Option (Right to Buy) |
M - Exercise | −2 773 | 21 084 | −11,62 | ||||
| 2017-07-05 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class A Common Stock |
S - Sale | −1 995 | 28 700 | −6,50 | 27,11 | −54 076 | 777 939 | |
| 2017-07-05 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class A Common Stock |
F - Taxes | −778 | 30 695 | −2,47 | 27,10 | −21 084 | 831 834 | |
| 2017-07-05 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class A Common Stock |
M - Exercise | 2 773 | 31 473 | 9,66 | 7,61 | 21 103 | 239 510 | |
| 2017-07-05 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Director Stock Option (Right to Buy) |
M - Exercise | −1 101 | 23 857 | −4,41 | ||||
| 2017-07-05 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class A Common Stock |
S - Sale | −790 | 28 700 | −2,68 | 27,03 | −21 354 | 775 770 | |
| 2017-07-05 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class A Common Stock |
F - Taxes | −311 | 29 490 | −1,04 | 26,90 | −8 366 | 793 281 | |
| 2017-07-05 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class A Common Stock |
M - Exercise | 1 101 | 29 801 | 3,84 | 7,61 | 8 379 | 226 786 | |
| 2017-06-30 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Director Stock Option (Right to Buy) |
M - Exercise | −1 178 | 24 958 | −4,51 | ||||
| 2017-06-30 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class A Common Stock |
S - Sale | −846 | 28 700 | −2,86 | 27,00 | −22 842 | 774 900 | |
| 2017-06-30 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class A Common Stock |
F - Taxes | −332 | 29 546 | −1,11 | 26,95 | −8 947 | 796 265 | |
| 2017-06-30 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class A Common Stock |
M - Exercise | 1 178 | 29 878 | 4,10 | 7,61 | 8 965 | 227 372 | |
| 2017-06-29 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Director Stock Option (Right to Buy) |
M - Exercise | −2 718 | 26 136 | −9,42 | ||||
| 2017-06-29 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class A Common Stock |
S - Sale | −1 959 | 28 700 | −6,39 | 27,24 | −53 368 | 781 860 | |
| 2017-06-29 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class A Common Stock |
F - Taxes | −759 | 30 659 | −2,42 | 27,25 | −20 683 | 835 458 | |
| 2017-06-29 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class A Common Stock |
M - Exercise | 2 718 | 31 418 | 9,47 | 7,61 | 20 684 | 239 091 | |
| 2017-06-29 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Director Stock Option (Right to Buy) |
M - Exercise | −4 319 | 28 854 | −13,02 | ||||
| 2017-06-29 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class A Common Stock |
S - Sale | −3 100 | 28 700 | −9,75 | 27,06 | −83 873 | 776 501 | |
| 2017-06-29 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class A Common Stock |
F - Taxes | −1 219 | 31 800 | −3,69 | 26,95 | −32 852 | 857 010 | |
| 2017-06-29 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class A Common Stock |
M - Exercise | 4 319 | 33 019 | 15,05 | 7,61 | 32 868 | 251 275 | |
| 2017-06-27 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Director Stock Option (Right to Buy) |
M - Exercise | −2 827 | 33 173 | −7,85 | ||||
| 2017-06-27 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Director Stock Option (Right to Buy) |
M - Exercise | −3 653 | 0 | −100,00 | ||||
| 2017-06-27 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class A Common Stock |
S - Sale | −4 635 | 28 700 | −13,90 | 27,46 | −127 286 | 788 159 | |
| 2017-06-27 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class A Common Stock |
F - Taxes | −795 | 33 335 | −2,33 | 27,05 | −21 505 | 901 712 | |
| 2017-06-27 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class A Common Stock |
M - Exercise | 2 827 | 34 130 | 9,03 | 7,61 | 21 513 | 259 729 | |
| 2017-06-27 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class A Common Stock |
F - Taxes | −1 050 | 31 303 | −3,25 | 27,05 | −28 402 | 846 746 | |
| 2017-06-27 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class A Common Stock |
M - Exercise | 3 653 | 32 353 | 12,73 | 7,78 | 28 420 | 251 706 | |
| 2017-06-27 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Director Stock Option (Right to Buy) |
M - Exercise | −7 013 | 3 653 | −65,75 | ||||
| 2017-06-27 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class A Common Stock |
S - Sale | −5 000 | 28 700 | −14,84 | 26,93 | −134 632 | 772 785 | |
| 2017-06-27 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class A Common Stock |
F - Taxes | −2 013 | 33 700 | −5,64 | 27,10 | −54 552 | 913 270 | |
| 2017-06-27 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class A Common Stock |
M - Exercise | 7 013 | 35 713 | 24,44 | 7,78 | 54 561 | 277 847 | |
| 2017-06-26 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Director Stock Option (Right to Buy) |
M - Exercise | −293 | 10 666 | −2,67 | ||||
| 2017-06-26 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class A Common Stock |
S - Sale | −209 | 28 700 | −0,72 | 27,25 | −5 696 | 782 109 | |
| 2017-06-26 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class A Common Stock |
F - Taxes | −84 | 28 909 | −0,29 | 27,00 | −2 268 | 780 543 | |
| 2017-06-26 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class A Common Stock |
M - Exercise | 293 | 28 993 | 1,02 | 7,78 | 2 280 | 225 566 | |
| 2017-06-22 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Director Stock Option (Right to Buy) |
M - Exercise | −2 155 | 10 959 | −16,43 | ||||
| 2017-06-22 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class A Common Stock |
S - Sale | −337 | 28 700 | −1,16 | 27,40 | −9 234 | 786 380 | |
| 2017-06-22 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class A Common Stock |
S - Sale | −1 200 | 29 037 | −3,97 | 27,35 | −32 820 | 794 162 | |
| 2017-06-22 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class A Common Stock |
F - Taxes | −618 | 30 237 | −2,00 | 27,10 | −16 748 | 819 423 | |
| 2017-06-22 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class A Common Stock |
M - Exercise | 2 155 | 30 855 | 7,51 | 7,78 | 16 766 | 240 052 | |
| 2017-06-22 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Director Stock Option (Right to Buy) |
M - Exercise | −871 | 13 114 | −6,23 | ||||
| 2017-06-22 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class A Common Stock |
S - Sale | −300 | 28 700 | −1,03 | 27,40 | −8 220 | 786 380 | |
| 2017-06-22 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class A Common Stock |
S - Sale | −322 | 29 000 | −1,10 | 27,45 | −8 839 | 796 050 | |
| 2017-06-22 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class A Common Stock |
F - Taxes | −249 | 29 322 | −0,84 | 27,20 | −6 773 | 797 558 | |
| 2017-06-22 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class A Common Stock |
M - Exercise | 871 | 29 571 | 3,03 | 7,78 | 6 776 | 230 062 | |
| 2017-06-20 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Director Stock Option (Right to Buy) |
M - Exercise | −6 472 | 13 985 | −31,64 | ||||
| 2017-06-20 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class A Common Stock |
S - Sale | −4 638 | 28 700 | −13,91 | 27,50 | −127 545 | 789 250 | |
| 2017-06-20 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class A Common Stock |
F - Taxes | −1 834 | 33 338 | −5,21 | 27,45 | −50 343 | 915 128 | |
| 2017-06-20 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class A Common Stock |
M - Exercise | 6 472 | 35 172 | 22,55 | 7,78 | 50 352 | 273 638 | |
| 2017-06-20 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Director Stock Option (Right to Buy) |
M - Exercise | −9 106 | 20 457 | −30,80 | ||||
| 2017-06-20 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class A Common Stock |
S - Sale | −6 530 | 28 700 | −18,54 | 27,54 | −179 856 | 790 484 | |
| 2017-06-20 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class A Common Stock |
F - Taxes | −2 576 | 35 230 | −6,81 | 27,50 | −70 840 | 968 825 | |
| 2017-06-20 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class A Common Stock |
M - Exercise | 9 106 | 37 806 | 31,73 | 7,78 | 70 845 | 294 131 | |
| 2017-06-16 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Director Stock Option (Right to Buy) |
M - Exercise | −1 255 | 29 563 | −4,07 | ||||
| 2017-06-16 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class A Common Stock |
S - Sale | −900 | 28 700 | −3,04 | 27,75 | −24 975 | 796 425 | |
| 2017-06-16 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class A Common Stock |
F - Taxes | −355 | 29 600 | −1,19 | 27,50 | −9 762 | 814 000 | |
| 2017-06-16 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class A Common Stock |
M - Exercise | 1 255 | 29 955 | 4,37 | 7,78 | 9 764 | 233 050 | |
| 2017-06-16 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Director Stock Option (Right to Buy) |
M - Exercise | −5 182 | 30 818 | −14,39 | ||||
| 2017-06-16 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class A Common Stock |
S - Sale | −3 740 | 28 700 | −11,53 | 28,03 | −104 845 | 804 559 | |
| 2017-06-16 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class A Common Stock |
F - Taxes | −1 442 | 32 440 | −4,26 | 27,95 | −40 304 | 906 698 | |
| 2017-06-16 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class A Common Stock |
M - Exercise | 5 182 | 33 882 | 18,06 | 7,78 | 40 316 | 263 602 | |
| 2017-05-11 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Director Stock Option (Right to Buy) |
A - Award | 6 000 | 6 000 | |||||
| 2017-05-11 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Director Stock Option (Right to Buy) |
A - Award | 36 000 | 36 000 | |||||
| 2016-05-13 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Director Stock Option (Right to Buy) |
A - Award | 6 000 | 6 000 | |||||
| 2016-05-13 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Director Stock Option (Right to Buy) |
A - Award | 36 000 | 36 000 | |||||
| 2015-05-11 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Director Stock Option (Right to Buy) |
A - Award | 6 000 | 6 000 | |||||
| 2015-05-11 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Director Stock Option (Right to Buy) |
A - Award | 36 000 | 36 000 | |||||
| 2014-05-12 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Director Stock Option (Right to Buy) |
A - Award | 6 000 | 6 000 | |||||
| 2014-05-12 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Director Stock Option (Right to Buy) |
A - Award | 36 000 | 36 000 | |||||
| 2014-03-17 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class A Common Stock |
S - Sale | −500 | 28 700 | −1,71 | 18,01 | −9 006 | 516 944 | |
| 2014-03-17 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class B Common Stock |
S - Sale | −6 000 | 3 900 | −60,61 | 41,00 | −246 001 | 159 901 | |
| 2014-03-17 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class A Common Stock |
S - Sale | −6 200 | 29 200 | −17,51 | 18,02 | −111 719 | 526 161 | |
| 2014-03-17 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class A Common Stock |
S - Sale | −24 000 | 35 400 | −40,40 | 18,55 | −445 258 | 656 755 | |
| 2014-03-17 |
|
4/A | NRCIA/B |
NATIONAL RESEARCH CORP
Class B Common Stock |
M - Exercise | 6 000 | 9 900 | 153,85 | 17,06 | 102 360 | 168 894 | |
| 2014-03-17 |
|
4/A | NRCIA/B |
NATIONAL RESEARCH CORP
Class A Common Stock |
M - Exercise | 36 000 | 59 400 | 153,85 | 8,49 | 305 640 | 504 306 | |
| 2014-03-12 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Director Stock Option (Right to Buy) |
M - Exercise | −6 000 | 0 | −100,00 | ||||
| 2014-03-12 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Director Stock Option (Right to Buy) |
M - Exercise | −36 000 | 0 | −100,00 | ||||
| 2014-03-12 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class B Common Stock |
F - Taxes | −2 475 | 7 425 | −25,00 | 41,33 | −102 292 | 306 875 | |
| 2014-03-12 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class B Common Stock |
M - Exercise | 6 000 | 9 900 | 153,85 | 17,06 | 102 360 | 168 894 | |
| 2014-03-12 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class A Common Stock |
F - Taxes | −16 257 | 43 143 | −27,37 | 18,80 | −305 632 | 811 088 | |
| 2014-03-12 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class A Common Stock |
M - Exercise | 36 000 | 59 400 | 153,85 | 8,49 | 305 640 | 504 306 | |
| 2013-12-05 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Director Stock Option (Right to Buy) |
M - Exercise | −8 100 | 0 | −100,00 | ||||
| 2013-12-05 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class A Common Stock |
S - Sale | −8 100 | 23 400 | −25,71 | 17,65 | −142 928 | 412 902 | |
| 2013-12-05 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class A Common Stock |
M - Exercise | 8 100 | 31 500 | 34,62 | 7,20 | 58 320 | 226 800 | |
| 2013-12-05 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Director Stock Option (Right to Buy) |
M - Exercise | −27 900 | 8 100 | −77,50 | ||||
| 2013-12-05 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Director Stock Option (Right to Buy) |
M - Exercise | −27 900 | 8 100 | −77,50 | ||||
| 2013-12-05 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class A Common Stock |
S - Sale | −27 900 | 23 400 | −54,39 | 17,79 | −496 447 | 416 375 | |
| 2013-12-05 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class A Common Stock |
M - Exercise | 27 900 | 51 300 | 119,23 | 7,20 | 200 880 | 369 360 | |
| 2013-11-19 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Director Stock Option (Right to Buy) |
M - Exercise | −6 000 | 0 | −100,00 | ||||
| 2013-11-19 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Director Stock Option (Right to Buy) |
M - Exercise | −4 195 | 0 | −100,00 | ||||
| 2013-11-19 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class B Common Stock |
S - Sale | −10 195 | 3 900 | −72,33 | 33,50 | −341 538 | 130 652 | |
| 2013-11-19 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class B Common Stock |
M - Exercise | 6 000 | 14 095 | 74,12 | 18,11 | 108 660 | 255 260 | |
| 2013-11-19 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class B Common Stock |
M - Exercise | 4 195 | 8 095 | 107,56 | 16,18 | 67 875 | 130 977 | |
| 2013-11-15 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Director Stock Option (Right to Buy) |
M - Exercise | −108 | 4 195 | −2,51 | ||||
| 2013-11-15 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class B Common Stock |
S - Sale | −108 | 3 900 | −2,69 | 33,50 | −3 618 | 130 650 | |
| 2013-11-15 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class B Common Stock |
M - Exercise | 108 | 4 008 | 2,77 | 16,18 | 1 747 | 64 849 | |
| 2013-11-15 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Director Stock Option (Right to Buy) |
M - Exercise | −1 697 | 4 303 | −28,28 | ||||
| 2013-11-15 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class B Common Stock |
S - Sale | −1 697 | 3 900 | −30,32 | 33,64 | −57 080 | 131 181 | |
| 2013-11-15 |
|
4 | NRCIA/B |
NATIONAL RESEARCH CORP
Class B Common Stock |
M - Exercise | 1 697 | 5 597 | 43,51 | 16,18 | 27 457 | 90 559 | |
| 2013-05-13 |
|
4 | NRCI |
NATIONAL RESEARCH CORP
Director Stock Option (Right to Buy) |
A - Award | 12 000 | 12 000 | |||||
| 2012-05-14 |
|
4 | NRCI |
NATIONAL RESEARCH CORP
Director Stock Option (Right to Buy) |
A - Award | 12 000 | 12 000 |
